The need for large scale randomized evidence

British Journal of Clinical Pharmacology

Volumn 43, Issue 4, 1997, Pages 349-353

  Baigent, C ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Meta analysis; Randomized controlled trial

Indexed keywords

CLINICAL TRIAL; INFORMATION PROCESSING; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; TREATMENT OUTCOME;

EID: 0030935980     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00569.x     Document Type: Review

References (25)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, Br Med J 1994; 308: 81-106.
2. Murray CJL, Lopez AD (eds). Global comparative assessments in the health sector: disease burden, expenditures and intervention packages. World Health Organization, Geneva, 1994.
3. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part I: Introduction and design. Br J Cancer 1976; 34. 585-612.
4. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II: Analysis and examples. Br J Cancer 1977; 35: 1-39.
5. Yusuf S, Collins R, Peto R. Why do we need some large simple randomized trials? Stat Med 1984; 3: 409-420.
6. Collins R, Peto R, Gray R, Parish S. Large-scale randomized evidence: trials and overviews. Chapter 2.4 In Oxford Textbook of Medicine, Volume 1 eds Weatherall D, Ledingham JGG, Warrell DA. Oxford University Press 1996, pp. 21-32.
7. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'infarto miocardico). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i: 397-402.
8. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311-322.
9. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15 (Part I) & 71-85 (Part II).
10. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15 (Part I) & 71-85 (Part II).
11. Cholesterol Treatment Trialists' (CTT) Collaboration. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol 1995; 75: 1130-1134.
12. Collins R, Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J 1991; 66: 250-255.
13. Collins R, Doll R, Peto R. Ethics of clinical trials. In Introducing new treatments for cancer. Practical, ethical and legal problems ed Williams CJ. John Wiley & Sons, 1992.
14. Sheldon TA. Please bypass the PORT. Observational studies of effectiveness run a poor second to randomized controlled trials. Br Med J 1994; 309: 142-143.
15. Peto R. Clinical trial methodology. Biomedicine Special Issue 1978; 28: 24-36.
16. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodologic quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
17. Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomized controlled trials: survey of published parallel group trials in obstetrics and gynaecology. Br Med J 1996; 312: 742-744.
18. Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith H Jr. Publication bias and clinical trials. Controlled Clinical Trials 1987; 8: 343-353.
19. Easterbrook PJ, Berlin JA, Gopelan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
20. Dickersin K, Min Y-I, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 1992; 267: 374-378.
21. Dickersin K, Min Y-I. Publication bias: the problem that won't go away. Ann NY Acad Sci 1993; 703: 135-146.
22. Counsell CE, Clarke MJ, Slattery J, Sandercock PAG. The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis. Br Med J 1994; 309: 1677-81.
23. Davey Smith G, Egger M. Misleading meta- analysis Br Med J 1995; 310: 742-754.
24. Chessells JM. Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects. Blood Reviews 1992; 6: 193-203.
25. The Cochrane Library. April 1996 issue, BMJ Publishing Group, London.